Tyra Biosciences appoints new principal accounting officer
Tyra Biosciences, Inc. named Julia Rueb, its Vice President of Finance, as the company’s principal accounting officer, effective April 1, 2026.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
Tyra Biosciences, Inc. named Julia Rueb, its Vice President of Finance, as the company’s principal accounting officer, effective April 1, 2026. She succeeds Chief Financial Officer Alan Fuhrman in this specific role, while he continues to serve as the company’s principal financial officer.
Rueb, age 40, has been Vice President, Finance since January 2024 and previously held senior accounting and controller roles at the company. Her background includes technical accounting and consulting positions at SOAProjects, van den Boom & Associates, and audit experience at Ernst & Young, primarily serving public life sciences companies.
8-K Event Classification
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
1 item
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Key Figures
Effective date of role change: April 1, 2026
Julia Rueb age: 40
VP Finance tenure start: January 2024
+1 more
4 metrics
Effective date of role change
April 1, 2026
Date Julia Rueb became principal accounting officer
Julia Rueb age
40
Age of new principal accounting officer
VP Finance tenure start
January 2024
Start of Julia Rueb’s role as Vice President, Finance
Ernst & Young tenure end
October 2020
End of Rueb’s employment at Ernst & Young LLP
Key Terms
principal accounting officer, principal financial officer, emerging growth company, Certified Public Accountant
4 terms
principal accounting officer financial
"designated Julia Rueb, Vice President, Finance of the Company, as the Company’s principal accounting officer"
The Principal Accounting Officer is the person responsible for making sure a company's financial records are accurate and follow the rules. They play a key role in preparing financial reports that show how well the company is doing. This helps investors, managers, and regulators trust the company's financial information.
principal financial officer financial
"Mr. Fuhrman continues to be the Company’s principal financial officer"
The principal financial officer is the senior executive who runs a company's financial operations: preparing and certifying financial reports, managing accounting controls, budgets and cash flow, and advising on financial strategy. Investors care about this role because its competence affects how trustworthy the company’s numbers are, how well it manages risk and capital needs, and the credibility of forecasts—like the chief navigator steering a firm's financial course.
emerging growth company regulatory
"Emerging growth company Item 5.02 Departure of Directors or Certain Officers"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Certified Public Accountant financial
"Ms. Rueb holds a Master’s degree in Accounting from the University of San Diego and is a Certified Public Accountant"
A certified public accountant (CPA) is a licensed accounting professional who has passed rigorous exams and met education and experience requirements to prepare, review, and officially certify financial statements and tax filings. For investors, a CPA's involvement is like a neutral referee confirming that a company's reported numbers are accurate and follow accounting rules, which improves trust in financial reports and lowers the risk of unexpected errors or misleading information.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What leadership change did Tyra Biosciences (TYRA) announce on April 1, 2026?
Tyra Biosciences appointed Vice President of Finance Julia Rueb as its principal accounting officer, effective April 1, 2026. She replaces Chief Financial Officer Alan Fuhrman in that specific role, while he remains the company’s principal financial officer.
Does Alan Fuhrman remain CFO of Tyra Biosciences (TYRA)?
Yes, Alan Fuhrman continues as Tyra Biosciences’ Chief Financial Officer and principal financial officer. The change only shifts the principal accounting officer designation to Vice President of Finance Julia Rueb, effective April 1, 2026.
What is Julia Rueb’s background before becoming principal accounting officer at TYRA?
Before being named principal accounting officer, Julia Rueb served as Tyra’s Vice President, Finance since January 2024. She previously held controller and technical accounting roles and worked at SOAProjects, van den Boom & Associates, and Ernst & Young, mainly with public life sciences companies.
Does Tyra Biosciences (TYRA) disclose any family relationships for Julia Rueb?
The company states that Julia Rueb has no family relationships with any of Tyra Biosciences’ directors or executive officers. This disclosure supports governance transparency regarding potential related-party or nepotism concerns in senior finance appointments.
What qualifications does Julia Rueb bring to her new role at Tyra Biosciences (TYRA)?
Julia Rueb holds a Master’s degree in Accounting from the University of San Diego and is a Certified Public Accountant. Her experience spans corporate controller roles, technical accounting consulting, and audit work focused on public life sciences companies.
AI-generated analysis. How Rhea-AI works. Not financial advice.
